New Biotech Offering Targets $426B Rare Disease Market
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
| Open | 46.20 | Prev Close | 46.07 |
| High | 46.20 | Low | 46.20 |
| Volume | 382 | Volume (Avg) | 3,592 |
| 52 Week High | 91.25 | 52 Week Low | 42.75 |
| Market Cap | 6.8B | PE Ratio | 13.57 |
General
| Name | Carmax Inc |
| Ticker | KMX |
| Exchange | NYSE |
| Sector | Consumer Cyclical |
| Industry | Auto & Truck Dealerships |
| Currency | USD |
| Country | USA |
| Fiscal Year End | February |
| Full Time Employees | 30,048 |
About Carmax Inc
CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles and related products in the United States. The company operates in two segments: CarMax Sales Operations and CarMax Auto Finance. The CarMax Sales Operations segment offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; used vehicle auctions; extended protection plans to customers at the time of sale; and reconditioning and vehicle repair services. The CarMax Auto Finance segment provides financing alternatives for retail customers across a range of credit spectrum and arrangements with various financial institutions. The company was founded in 1993 and is based in Richmond, Virginia.
Highlights
| Analyst Target | 54.97 |
| Market Cap | 6,784,200,000 |
| PE Ratio | 13.57 |
| PEG Ratio | 0.64 |
| EBITDA | 1,127,292,032 |
Valuation
| Trailing PE | 13.51 |
| Forward PE | 13.26 |
| Price/Sales (Trailing 12 Mt.) | 0.24 |
| Price/Book (Most Recent Quarter) | 1.09 |
Technicals
| Beta | 1.26 |
| 52 Week High | 91.25 |
| 52 Week Low | 42.75 |
| 50 Day Average | -18.89% |
| 200 Day Average | -33.33% |
Earnings
Ray Dalio Doubts Any Central Bank Would Take On Bitcoin As Reserve Currency Despite Many Seeing It As Alternative Money: 'There's No Privacy'
Billionaire hedge fund manager Ray Dalio expressed skepticism Thursday that central banks will consider holding Bitcoin (CRYPTO: BTC) as a reserve currency, citing privacy concerns.
Nvidia CEO Jensen Huang Reportedly Frustrated As Trump's Commerce Secretary Slows UAE Chips Deal Over China Link
Nvidia's multibillion-dollar chip deal with the UAE has stalled for months, reportedly frustrating CEO Jensen Huang as Commerce Secretary Howard Lutnick links approval to Emirati investments and raises concerns over the Gulf nation's ties to China.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
George Soros' philanthropy reaches for new ideas as it grapples with the limits of its power
NEW YORK (AP) — Open Society Foundations, the family philanthropy of hedge fund billionaire , has consistently been one of the largest funders of around the world. But what that means has changed in recent years, with a new focus on addressing inequality.
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Mark Zuckerberg's Meta May Lean On Rival Google To Improve Ad Targeting Despite Billions Spent On In-House AI
Meta Platforms Inc. (NASDAQ: META) is reportedly in early talks with Alphabet Inc.
Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline
According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Here's How Much You Would Have Made Owning United Rentals Stock In The Last 20 Years
United Rentals (NYSE: URI) has outperformed the market over the past 20 years by 12.61% on an annualized basis producing an average annual return of 21.43%. Currently, United Rentals has a market capitalization of $59.92 billion.
Microsoft resolves European Union probe into Teams
LONDON (AP) — European Union regulators have accepted Microsoft's to Teams, resolving a long-running antitrust investigation that targeted the company's messaging and videoconferencing app.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Embed-Chart-H-1B-Visas-Explainer-Application Approvals, ADVISORY
H-1B-VISAS-EXPLAINER-APPLICATION APPROVALS — Chart. The following digital embed shows the number of approved H1-B applications by type since 2010. This chart is current as of Sept. 22, 2025 and will not update. Source: Department of Homeland Security
'Greedy People Would Never Ask That Question,' Ramsey Says, Reassuring Oil Worker That Ambition For Family Isn't Greed
Dave Ramsey reassures young father that earning more money does not make him greedy. Greed comes from the heart, not a paycheck.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Europe urgently needs to solve its Russian drone problem, Baltic officials say
VINSKI, Estonia (AP) — Estonia is extending a fence along its border with Russia and building anti-tank ditches and bunkers in preparation for a potential conflict with Moscow. But those defenses won’t guard against the threat it and its NATO allies face from Russian drones and .
Trump files $15 billion defamation lawsuit against The New York Times
NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Asian shares trade mixed after Wall Street sets new records
TOKYO (AP) — Asian shares traded mixed on Tuesday after Wall Street set new records as investor anticipation grew that the U.S. Federal Reserve will announce the first cut of the year on its main interest rate.
Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs
President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?
Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and The Trade Desk—while biotech trial updates and mixed analyst calls pressured others.
The Big Mac That Cost $380,000: Why The Early Bitcoin Believer Who Paid 3.5 BTC For The Burger Has Zero Regrets
The story about the purchase of Papa John’s pizzas using Bitcoin (CRYPTO: BTC) is legendary, but did you know that someone also once paid for a Big Mac with the world’s largest cryptocurrency
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
‘Race against time’ to remove rubble after recent earthquake in Afghanistan’s east, says UN
The United Nations says aid workers are still in a “race against time” to remove rubble and rebuild after the eastern Afghanistan last month, killing at least 2,200 people and cutting off remote areas.
Opendoor Is A 'Total Clown Show' Legendary Investor Says
Legendary hedge fund manager George Noble called Opendoor Technologies Inc.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint
SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.
Nucor And Reliance Seen As Steel's Strongest Defenders Against Market Challenges
NA steel sector struggles with pricing & demand, leaving investors cautious. HRC prices down 6%, but mills gaining market share & utilization up.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Why Rivian Automotive Stock Is Gaining Today?
Rivian stock climbs after breaking ground on a multibillion-dollar Georgia EV plant.
Jaguar Land Rover says a shutdown will continue until at least Oct 1 after cyberattack
LONDON (AP) — said Tuesday that its production lines, shut down after a cyberattack in August, will remain at a halt until at least Oct. 1.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
British department store Harrods warns customers that some personal details taken in data breach
LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.
California to extend cap-and-trade program aimed at advancing state climate goals
SACRAMENTO, Calif. (AP) — California will extend a key climate program under a bill state lawmakers passed Saturday, sending the measure to Gov. Gavin Newsom, who has championed it as a crucial tool to respond to the Trump administration’s environmental rollbacks.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Why Redwire Stock Is Gaining Today
Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.
Zelenskyy calls for a European air defense system as Russian strike wounds 20 in Ukrainian city
KYIV, Ukraine (AP) — Russian forces bombarded the southern Ukrainian city of Zaporizhzhia with rockets overnight, wounding 20 people, including four children, President Volodymyr Zelenskyy said Tuesday as he urged European leaders to make the continent safe by building an ambitious air defense umbrella.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.